Adaptimmune Therapeutics shares owned by Stifel Financial
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Stifel Financial
from 13F filings
Historical chart of Stifel Financial investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Stifel Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Stifel Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $5.5k | 23k | 0.24 |
| 2025-03-31 | $5.2k | 27k | 0.20 |
| 2024-12-31 | $14k | 27k | 0.54 |
| 2024-09-30 | $26k | 28k | 0.95 |
| 2024-06-30 | $27k | 28k | 0.97 |
| 2024-03-31 | $38k | 24k | 1.58 |
| 2023-12-31 | $22k | 27k | 0.79 |
| 2023-09-30 | $23k | 30k | 0.78 |
| 2023-06-30 | $28k | 30k | 0.93 |
| 2023-03-31 | $33k | 30k | 1.09 |
| 2022-12-31 | $45k | 31k | 1.46 |
| 2022-09-30 | $32k | 30k | 1.08 |
| 2022-06-30 | $50k | 30k | 1.69 |
| 2022-03-31 | $61k | 30k | 2.06 |
| 2021-12-31 | $143k | 38k | 3.75 |
| 2021-09-30 | $229k | 44k | 5.18 |
| 2021-06-30 | $185k | 43k | 4.27 |
| 2021-03-31 | $178k | 34k | 5.30 |
| 2020-12-31 | $165k | 31k | 5.39 |
| 2020-09-30 | $1.3M | 167k | 7.98 |
| 2020-06-30 | $154k | 15k | 9.98 |
| 2018-09-30 | $1.2M | 91k | 13.45 |